Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CMKLR1 Stable Cell Line

    [CAT#: S01YF-0923-PY31]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX279 Magic™ Rat CMKLR1 in Vitro Calcium Flux Assay Rat CHO-K1-Gα16 Calcium Flux Assay

    Product Information

    Target Protein
    CMKLR1
    Target Family
    Chemoattractant Family
    Target Protein Species
    Human
    Host Cell Type
    DU145;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Cardiovascular Research
    Related Diseases
    Monckeberg Arteriosclerosis;Cardiovascular Syphilis
    Gene ID
    Human: 1240
    UniProt ID
    Human: Q99788

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Chemokine-like receptor 1 (CMKLR1) has emerged as a pivotal player in various physiological and pathological processes. One of the promising areas of research is its potential application in demyelinating diseases, where novel CMKLR1 inhibitors are being explored. Another study has highlighted the upregulation of CMKLR1 in human bone marrow-derived mesenchymal stem cells compared to human embryonic fibroblasts, suggesting a potential role in stem cell recruitment and differentiation. Furthermore, the Chemerin/CMKLR1 axis has been implicated in the development of diabetic cardiomyopathy, where it promotes inflammation and pyroptosis. Silencing of the CMKLR1 gene might offer protection against this condition. Additionally, CMKLR1 has been identified as a functional receptor for amyloid-β peptide, suggesting its potential role in neurodegenerative diseases. In essence, CMKLR1's involvement in various cellular processes, from stem cell differentiation to inflammation, makes it a promising target for therapeutic interventions in a range of diseases.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CMKLR1 Stable Cell Line (S01YF-0923-PY31). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat David (Verified Customer)

    What are the potential therapeutic implications of CMKLR1 research? Dec 13 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Understanding CMKLR1's role in cellular pathways can lead to the development of targeted therapies and drug interventions. Dec 13 2020

    chat Deborah (Verified Customer)

    Are there specific challenges in researching CMKLR1 in stabilized cell lines? Aug 20 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    While challenges specific to CMKLR1 are not mentioned, cell line stabilization often requires addressing issues like genomic integrity and DNA damage repair. Aug 20 2022

    Published Data

    Fig.1 Chemerin improves T-cell-mediated cell cytotoxicity in tumor cells.

    DU145 cells underwent transfection with control or designated siRNA sequences for 48 hours. Subsequently, these transfected cells received either a control (PBS) or chemerin treatment prior to T-cell-induced cytotoxicity assessment. The impact of 6 nmol/L chemerin on cytotoxicity was nullified upon CMKLR1 knockdown (*, P < 0.05; n = 3 independent replicates).

    Ref: Rennier, Keith, et al. "Chemerin reactivates PTEN and suppresses PD-L1 in tumor cells via modulation of a novel CMKLR1-mediated signaling cascade." Clinical cancer research 26.18 (2020): 5019-5035.

    Pubmed: 32605911

    DOI: 10.1158/1078-0432.CCR-19-4245

    Research Highlights

    Mayer S, et al. "The tumor microenvironment shows a hierarchy of cell-cell interactions dominated ." Nature communications, 2023.
    The tumor microenvironment (TME) is a complex network of non-malignant cells that play a crucial role in cancer biology. To understand this complexity, researchers have developed an experimental-mathematical approach to break down the TME into smaller circuits of interacting cell types. Through the analysis of single-cell RNA sequencing data from female breast cancer patients, a hierarchical network of interactions was identified, with cancer-associated fibroblasts (CAFs) at the top secreting factors mainly towards tumor-associated macrophages (TAMs). By isolating the strongest two-cell circuit motif in vitro, researchers were able to mimic the hierarchy of in vivo interactions and test the effect of specific ligand-receptor interactions on cell dynamics and function. This approach led to the discovery of a mediator of CAF-TAM interactions, RARRES2, and its receptor CMKLR1. This study highlights the importance of identifying small circuits within the TME in simplifying its complexity and developing potential strategies to modify its function.
    Pubmed: 37726308   DOI: 10.1038/s41467-023-41518-w

    Hernandez J, et al. "n-3 Polyunsaturated Fatty Acids Modulate LPS-Induced ARDS and the Lung-Brain Axis ." International journal of molecular sciences, 2023.
    Specialized pro-resolving mediators (SPMs) and specifically Resolvin E1 (RvE1) have been found to effectively terminate inflammation and aid in healing during lung diseases like acute respiratory distress syndrome (ARDS). Despite primarily affecting the lungs, many ARDS patients also experience neurocognitive impairments. In order to explore the correlation between the lung and brain during ARDS and the potential therapeutic use of SPMs and its derivatives, experiments were conducted on fat-1 mice bred with RvE1 receptor knockout mice. ARDS was induced using lipopolysaccharide (LPS, 10 microg) administered through the intratracheal route. Mice were sacrificed at 0 h, 4 h, 24 h, 72 h, and 120 h following inflammation, and various assessments including RT-PCR, multiplex, immunohistochemistry, Western blot, and LC-MS/MS were performed to gauge the effects on the lung, liver, and brain. RT-PCR and protein analysis revealed a raise in inflammatory signaling in the hypothalamus, despite low signaling in the peripheral regions, due to inflammation triggered by LPS. Immunohistochemical staining was able to determine neutrophil recruitment in multiple brain structures. This study shows that during ARDS, immune cells go through the brain, interfacing with the immune system rather than using cytokines. Furthermore, the absence of RvE1 receptors along with heightened levels of omega-3 polyunsaturated fatty acids in fat-1 mice changed the interactions between the lung and brain during ARDS by modifying the levels of various inflammatory and lipid mediators as well as glial activity markers.
    Pubmed: 37686333   DOI: 10.3390/ijms241713524

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare